Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Phys Lipids ; 191: 153-62, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26386399

ABSTRACT

The lysophosphatidylcholine analogue edelfosine is a potent antitumor and antiparasitic drug that targets cell membranes. Previous studies have shown that edelfosine alters membrane domain organization inducing internalization of sterols and endocytosis of plasma membrane transporters. These early events affect signaling pathways that result in cell death. It has been shown that edelfosine preferentially partitions into more rigid lipid domains in mammalian as well as in yeast cells. In this work we aimed at investigating the effect of edelfosine on membrane domain organization using monolayers prepared from whole cell lipid extracts of cells treated with edelfosine compared to control conditions. In Langmuir monolayers we were able to detect important differences to the lipid packing of the membrane monofilm. Domain formation visualized by means of Brewster angle microscopy also showed major morphological changes between edelfosine treated versus control samples. Importantly, edelfosine resistant cells defective in drug uptake did not display the same differences. In addition, co-spread samples of control lipid extracts with edelfosine added post extraction did not fully mimic the results obtained with lipid extracts from treated cells. Altogether these results indicate that edelfosine induces changes in membrane domain organization and that these changes depend on drug uptake. Our work also validates the use of monolayers derived from complex cell lipid extracts combined with Brewster angle microscopy, as a sensitive approach to distinguish between conditions associated with susceptibility or resistance to lysophosphatidylcholine analogues.


Subject(s)
Cell Membrane/chemistry , Phospholipid Ethers/chemistry , Saccharomyces cerevisiae/metabolism , Cell Membrane/drug effects , Cell Membrane/metabolism , Compressive Strength , Endocytosis , Membrane Microdomains/chemistry , Membrane Microdomains/drug effects , Membrane Microdomains/metabolism , Phosphodiesterase Inhibitors/pharmacology , Phospholipid Ethers/pharmacology , Saccharomyces cerevisiae/growth & development
2.
Chem Phys Lipids ; 167-168: 33-42, 2013.
Article in English | MEDLINE | ID: mdl-23384478

ABSTRACT

Understanding lipid-protein interactions to enhance our knowledge of membrane architecture is a critical step in the development of novel therapeutic measures to respond to the drastic rise of drug resistant microorganisms. Escherichia coli contains a small archetypal inner membrane multidrug resistance protein, EmrE, that must multimerize to be functional but this multimerization is difficult to demonstrate in vivo. We studied three major E. coli lipids (phosphatidylethanolamine, phosphatidylglycerol and cardiolipin) that varied in head group structure, acyl chain length and saturation. These were investigated both in the presence and absence of EmrE to determine which lipid(s) EmrE influenced most strongly. Langmuir monolayers and Brewster angle microscopy demonstrated that varying each head group, acyl chain length and saturation contributed to differences in membrane packing and affected lipid-protein associations. Long unsaturated anionic lipids were influenced most strongly by EmrE. Shorter acyl chains initiated string-like formations of EmrE clusters, whereas longer chains contributed to enhance protein clustering. Longer partially unsaturated acyl chains in phosphatidylglycerol showed a significant surface pressure decrease in the presence of the protein, indicating that the monolayer was destabilized. Interestingly, longer unsaturated chains of cardiolipin formed the most stable monolayer in the presence of EmrE. These studies indicate cardiolipin acyl chains that hydrophobically match protein helical lengths stabilize EmrE structural forms.


Subject(s)
Antiporters/ultrastructure , Escherichia coli Infections/microbiology , Escherichia coli Proteins/ultrastructure , Escherichia coli/cytology , Membrane Lipids/chemistry , Antiporters/analysis , Cardiolipins/chemistry , Drug Resistance, Bacterial , Escherichia coli Infections/drug therapy , Escherichia coli Proteins/analysis , Humans , Phosphatidylethanolamines/chemistry , Phosphatidylglycerols/chemistry
3.
Chem Phys Lipids ; 165(2): 216-24, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22227110

ABSTRACT

A detailed understanding of biomembrane architecture is still a challenging task. Many in vitro studies have shown lipid domains but much less information is known about the lateral organization of membrane proteins because their hydrophobic nature limits the use of many experimental methods. We examined lipid domain formation in biomimetic Escherichia coli membranes composed of phosphatidylethanolamine and phosphatidylglycerol in the absence and presence of 1% and 5% (mol/mol) membrane multidrug resistance protein, EmrE. Monolayer isotherms demonstrated protein insertion into the lipid monolayer. Subsequently, Brewster angle microscopy was applied to image domains in lipid matrices and lipid-protein mixtures. The images showed a concentration dependent impact of the protein on lipid domain size and shape and more interestingly distinct coexisting protein clusters. Whereas lipid domains varied in size (14-47µm), protein clusters exhibited a narrow size distribution (2.6-4.8µm) suggesting a non-random process of cluster formation. A 3-D display clearly indicates that these proteins clusters protrude from the membrane plane. These data demonstrate distinct co-existing lipid domains and membrane protein clusters as the monofilm is being compressed and illustrate the significant mutual impact of lipid-protein interactions on lateral membrane architecture.


Subject(s)
Antiporters/analysis , Escherichia coli Proteins/analysis , Escherichia coli/chemistry , Membrane Microdomains/ultrastructure , Phosphatidylethanolamines/chemistry , Phosphatidylglycerols/chemistry , Escherichia coli/ultrastructure , Lipid Bilayers/chemistry , Membrane Microdomains/chemistry
4.
Environ Sci Technol ; 46(2): 1285-92, 2012 Jan 17.
Article in English | MEDLINE | ID: mdl-22148580

ABSTRACT

Souring in the Medicine Hat Glauconitic C field, which has a low bottom-hole temperature (30 °C), results from the presence of 0.8 mM sulfate in the injection water. Inclusion of 2 mM nitrate to decrease souring results in zones of nitrate-reduction, sulfate-reduction, and methanogenesis along the injection water flow path. Microbial community analysis by pyrosequencing indicated dominant community members in each of these zones. Nitrate breakthrough was observed in 2-PW, a major water- and sulfide-producing well, after 4 years of injection. Sulfide concentrations at four other production wells (PWs) also reached zero, causing the average sulfide concentration in 14 PWs to decrease significantly. Interestingly, oil produced by 2-PW was depleted of toluene, the preferred electron donor for nitrate reduction. 2-PW and other PWs with zero sulfide produced 95% water and 5% oil. At 2 mM nitrate and 5 mM toluene, respectively, this represents an excess of electron acceptor over electron donor. Hence, continuous nitrate injection can change the composition of produced oil and nitrate breakthrough is expected first in PWs with a low oil to water ratio, because oil from these wells is treated on average with more nitrate than is oil from PWs with a high oil to water ratio.


Subject(s)
Bacteria/metabolism , Extraction and Processing Industry/methods , Nitrates/chemistry , Petroleum/analysis , Toluene/chemistry , Sulfates , Sulfides , Time Factors
5.
J Biomed Nanotechnol ; 6(2): 145-52, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20738068

ABSTRACT

Given the current interest in the pulmonary route for targeted drug delivery, assessing the impact of drug delivery vehicles on the surfactant layer lining the surface of the lung alveoli is critical. As gelatin-based nanoparticles are one such vehicle, this study addresses their interaction with the major saturated phospholipid component of native lung surfactant, dipalmitoylphosphatidylcholine (DPPC). Nanoparticles are colloidal particles in the size range of 1 to 1000 nm that are presently investigated for site-specific drug delivery in the emerging field of nanomedicine. Monolayer studies of DPPC films were performed both in the presence and absence of nanoparticles in order to assess the interaction in terms of average molecular areas occupied at given surface pressures. In Brewster angle microscopy experiments, nanoparticles significantly changed the shape and reduced the size of DPPC domains suggesting a considerable interaction of the two systems. For safe pulmonary drug delivery, understanding this interaction is a prerequisite so nanoparticles can be a feasible alternative to more conventional therapies in the future.


Subject(s)
1,2-Dipalmitoylphosphatidylcholine/chemistry , Gelatin/chemistry , Microscopy/methods , Nanoparticles/chemistry , Colloids , Drug Delivery Systems/methods , Lipids/chemistry , Models, Biological , Nebulizers and Vaporizers , Pulmonary Alveoli , Surface Properties
6.
Chem Phys Lipids ; 163(1): 82-93, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19799887

ABSTRACT

Antimicrobial peptides are naturally produced by numerous organisms including insects, plants and mammals. Their non-specific mode of action is thought to involve the transient perturbation of bacterial membranes but the molecular mechanism underlying the rearrangement of the lipid molecules to explain the formation of pores and micelles is still poorly understood. Biological membranes mostly adopt planar lipid bilayers; however, antimicrobial peptides have been shown to induce non-lamellar lipid phases which may be intimately linked to their proposed mechanisms of action. This paper reviews antimicrobial peptides that alter lipid phase behavior in three ways: peptides that induce positive membrane curvature, peptides that induce negative membrane curvature and peptides that induce cubic lipid phases. Such structures can coexist with the bilayer structure, thus giving rise to lipid polymorphism induced upon addition of antimicrobial peptides. The discussion addresses the implications of induced lipid phases for the mode of action of various antimicrobial peptides.


Subject(s)
Anti-Infective Agents/chemistry , Antimicrobial Cationic Peptides/chemistry , Lipid Bilayers/chemistry , Calorimetry, Differential Scanning , Magainins , Models, Biological , Phase Transition , Transition Temperature , Xenopus Proteins/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...